Parsons Capital Management Inc/Ri
Source: SEC Form 13F · as of Mar 2026Parsons Capital Management Inc/Ri holds 4 biotech & pharma companies tracked by BioSniper, totaling $4.0M in value as of Mar 2026 (SEC Form 13F).
Companies held
4
Total value held
$4.0M
BioSniper AIPage evidence connected
Prepared research question
What matters most for RELMADA THERAPEUTICS, INC. (RLMD)—catalysts, financial risk and supporting evidence?
Run cited research
Traceable citations · Unknowns marked
| Company | Shares | Value |
|---|---|---|
| RLMDRELMADA THERAPEUTICS, INC. | 352,500 | $2.5M |
| GILDGILEAD SCIENCES, INC. | 5,796 | $808K |
| SNYSanofi | 11,541 | $556K |
| CLNNClene Inc. | 37,243 | $184K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.